Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | BLM | P54132 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | RGS12 | O14924 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4626004 | 1.00 | MAPT (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL158168 | 1.00 | MAPT (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL5324038 | 0.90 | USP2 (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL5283079 | 0.90 | USP2 (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL2971633 | 0.88 | GRIA1 (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL2971635 | 0.88 | GRIA1 (0.47) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL5282915 | 0.88 | USP2 (0.46) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL23682935 | 0.86 | GRIA1 (0.46) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL13205282 | 0.85 | TSHR (0.42) | MAPTCYP2C9MEN1KMT2ABLM | |
| SCHEMBL5285947 | 0.84 | USP2 (0.50) | MAPTCYP2C9MEN1KMT2ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2871 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731268-A1 | CROSS-LINKED VESICLES WITH LOW-BOILING POINT FLUORINATED COMPOUND | Bracco Suisse SA (CH) | 2026-04-29 | — | — | EP | claimed |
| US-20260014283-A1 | ULTRASOUND-SENSITIVE PEPTIDE PARTICLES FOR SPATIALLY RESOLVED MOLECULE DELIVERY AND METHODS OF USING THE SAME | PENN STATE RES FOUND (US) | 2026-01-15 | — | — | US | claimed |
| EP-4637837-A1 | CATIONIC CROSS-LINKED VESICLES | Bracco Suisse SA (CH) | 2025-10-29 | — | — | EP | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| EP-4554957-A1 | ANTIVIRAL CYCLIC COMPOUNDS | Universiteit Utrecht Holding B.V. (NL) | 2025-05-21 | — | — | EP | claimed |
| WO-2025090926-A1 | ULTRASOUND-SENSITIVE PEPTIDE PARTICLES WITH SURFACE-BOUND GENE EDITING TOOLS FOR SPATIALLY RESOLVED MOLECULE DELIVERY | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-05-01 | — | — | WO | claimed |
| CN-119868594-A | Method for radiolabelling GRPR antagonist and kit thereof | 诺华股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | claimed |
| CN-119715853-A | Semi-quantitative assessment method for substitution degree of non-protein amino acid | 遵义医科大学 | 2025-03-28 | — | — | CN | claimed |
| EP-4522221-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS | Entrada Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | claimed |
| US-20040072743-A1 | Pharmaceutical composition of modified pna molecules | PANTHECO A/S (DK) | 2004-04-15 | — | — | US | claimed |
| EP-1296718-A1 | PHARMACEUTICAL COMPOSITION OF MODIFIED PNA MOLECULES | Pantheco A/S (DK) | 2003-04-02 | — | — | EP | claimed |
| WO-2001076636-A2 | PHARMACEUTICAL COMPOSITION OF MODIFIED PNA MOLECULES | PANTHECO A/S (DK) | 2001-10-18 | — | — | WO | claimed |
| US-6262229-B1 | OCTAPEPTIDES | BIOMEASURE INCORPORATED | 2001-07-17 | — | — | US | claimed |
| US-6232305-B1 | ANTICANCER AGENTS; BONE DISORDERS; ANTIARTHRITIC AGENTS; RESPIRATORY SYSTEM DISORDERS | NAEJA PHARMACEUTICAL INC. (CA) | 2001-05-15 | — | — | US | claimed |
| EP-1025127-A1 | MSH-RECEPTOR SUBTYPE SELECTIVE CYCLIC PEPTIDES | Wapharm AB (SE) | 2000-08-09 | — | — | EP | claimed |
| EP-0950046-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (CA) | 1999-10-20 | — | — | EP | claimed |
| WO-1998037097-A1 | MSH-RECEPTOR SUBTYPE SELECTIVE CYCLIC PEPTIDES | WAPHARM AB (SE) | 1998-08-27 | — | — | WO | claimed |
| WO-1998012176-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (US) | 1998-03-26 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |